Cargando…
Economic burden of illness of acute coronary syndromes: medical and productivity costs
BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or cor...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042911/ https://www.ncbi.nlm.nih.gov/pubmed/21314995 http://dx.doi.org/10.1186/1472-6963-11-35 |
_version_ | 1782198572326846464 |
---|---|
author | Zhao, Zhenxiang Winget, Melissa |
author_facet | Zhao, Zhenxiang Winget, Melissa |
author_sort | Zhao, Zhenxiang |
collection | PubMed |
description | BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG). METHODS: Commercially insured individuals, aged 18-64, with an emergency room (ER) visit or hospitalization accompanied by an ACS diagnosis (index event) were identified from a large claims database between 01/2004 and 12/2005 with a 1-year follow-up period. Patients who had an ACS diagnosis in the 12 months prior to their index event were excluded. Patients were divided into 3 groups according to treatment strategies during the index event: MM, PCI, or CABG. A subset of patients was identified for the productivity cost analysis exploring short-term disability and absenteeism costs. Multivariate generalized linear models were performed to examine the ACS costs by 3 different treatment strategies. RESULTS: A total of 10,487 patients were identified for the medical cost analysis. The total 1-year medical costs (index event costs plus the 1-year follow-up costs) were lowest for MM patients ($34,087), followed by PCI patients ($52,673) and CABG patients ($86,914). Of the 3,080 patients in the productivity costs analysis, 2,454 patients were identified in the short-term disability cohort and 626 patients were identified in the absenteeism cohort. Both the estimated mean total 1-year short-term disability and absenteeism costs were highest for CABG patients ($17,335, $14,960, respectively) compared to MM patients ($6,048, $9,826, respectively) and PCI patients ($9,221, $9,460, respectively). CONCLUSIONS: Both total 1-year medical costs and 1-year productivity costs are substantial for working-aged individuals with ACS. These costs differ according to the type of treatment strategy, with CABG having higher costs compared to either PCI or MM. |
format | Text |
id | pubmed-3042911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30429112011-02-23 Economic burden of illness of acute coronary syndromes: medical and productivity costs Zhao, Zhenxiang Winget, Melissa BMC Health Serv Res Research Article BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG). METHODS: Commercially insured individuals, aged 18-64, with an emergency room (ER) visit or hospitalization accompanied by an ACS diagnosis (index event) were identified from a large claims database between 01/2004 and 12/2005 with a 1-year follow-up period. Patients who had an ACS diagnosis in the 12 months prior to their index event were excluded. Patients were divided into 3 groups according to treatment strategies during the index event: MM, PCI, or CABG. A subset of patients was identified for the productivity cost analysis exploring short-term disability and absenteeism costs. Multivariate generalized linear models were performed to examine the ACS costs by 3 different treatment strategies. RESULTS: A total of 10,487 patients were identified for the medical cost analysis. The total 1-year medical costs (index event costs plus the 1-year follow-up costs) were lowest for MM patients ($34,087), followed by PCI patients ($52,673) and CABG patients ($86,914). Of the 3,080 patients in the productivity costs analysis, 2,454 patients were identified in the short-term disability cohort and 626 patients were identified in the absenteeism cohort. Both the estimated mean total 1-year short-term disability and absenteeism costs were highest for CABG patients ($17,335, $14,960, respectively) compared to MM patients ($6,048, $9,826, respectively) and PCI patients ($9,221, $9,460, respectively). CONCLUSIONS: Both total 1-year medical costs and 1-year productivity costs are substantial for working-aged individuals with ACS. These costs differ according to the type of treatment strategy, with CABG having higher costs compared to either PCI or MM. BioMed Central 2011-02-14 /pmc/articles/PMC3042911/ /pubmed/21314995 http://dx.doi.org/10.1186/1472-6963-11-35 Text en Copyright ©2011 Zhao and Winget; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhao, Zhenxiang Winget, Melissa Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title_full | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title_fullStr | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title_full_unstemmed | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title_short | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
title_sort | economic burden of illness of acute coronary syndromes: medical and productivity costs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042911/ https://www.ncbi.nlm.nih.gov/pubmed/21314995 http://dx.doi.org/10.1186/1472-6963-11-35 |
work_keys_str_mv | AT zhaozhenxiang economicburdenofillnessofacutecoronarysyndromesmedicalandproductivitycosts AT wingetmelissa economicburdenofillnessofacutecoronarysyndromesmedicalandproductivitycosts |